SCHEMBL6445748

SCHEMBL6445748

Cc1cc(N)ccc1-n1cncn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
MAPT P10636 4/20 0.49
LMNA P02545 3/20 0.49
KDM4E B2RXH2 3/20 0.49
MEN1 O00255 2/20 0.49
THRB P10828 2/20 0.49
KMT2A Q03164 2/20 0.49
ALOX15 P16050 1/20 0.49
GAA P10253 2/20 0.45
NR4A1 P22736 1/20 0.45
PTK2B Q14289 1/20 0.45
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAD52 P43351 1/20 0.40
GFER P55789 1/20 0.40
S1PR3 Q99500 1/20 0.38
PDE10A Q9Y233 1/20 0.37
CASP1 P29466 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31285496 0.86 ALDH1A1 (0.49) ALDH1A1MAPTLMNAKDM4EMEN1
SCHEMBL16944266 0.82 POLB (0.42) ALDH1A1KDM4EKMT2ACYP1A2CYP3A4
SCHEMBL20335460 0.79 L3MBTL1 (0.43) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL7935214 0.79 CYP1A2 (0.40) ALDH1A1MAPTLMNAKDM4EMEN1
SCHEMBL2658961 0.79 CYP1A2 (0.54) ALDH1A1MAPTLMNAKDM4EMEN1
SCHEMBL994065 0.79 ALDH1A1 (0.46) ALDH1A1MAPTLMNAKDM4EMEN1
SCHEMBL17242393 0.79 APOBEC3A (0.50) MEN1KMT2AS1PR3APOBEC3AAPOBEC3G
SCHEMBL13749025 0.79 LMNA (0.39) ALDH1A1LMNAKDM4EMEN1KMT2A
SCHEMBL26031153 0.79 CYP3A4 (0.47) ALDH1A1KDM4EMEN1KMT2ACYP1A2
SCHEMBL28045824 0.79 CYP2C9 (0.41) ALDH1A1LMNAKDM4ECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3342765-B1 CATHEPSIN K INHIBITOR AND APPLICATION THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2021-09-15 EP disclosed
EP-3342765-A1 CATHEPSIN K INHIBITOR AND APPLICATION THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2018-07-04 EP disclosed
US-7205324-B2 Inhibitors of IMPDH enzyme BRISTOL-MYERS SQUIBB COMPANY (US) 2007-04-17 US disclosed
US-20050143384-A1 Amide thiadiazole inhibitors of plasminogen activator inhibitor-1 BRISTOL-MYERS SQUIBB COMPANY 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143384-A1 Amide thiadiazole inhibitors of plasminogen activator inhibitor-1 SERPINE1, SERPINC1, SERPINB1 ALDH1A1 212/4885MAPT 3346/4885LMNA 1668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.